Interventional Cardiology 

About: Interventional Cardiology is an academic journal published by Pulsus Group. The journal publishes majorly in the area(s): Percutaneous coronary intervention & Stent. It has an ISSN identifier of 1755-5302. It is also open access. Over the lifetime, 657 publications have been published receiving 1660 citations.

Femoral vascular access-site complications in the cardiac catheterization laboratory: diagnosis and management

Abstract: Vascular access-site complications remain a major cause of morbidity and mortality with cardiac catheterization and percutaneous intervention using the femoral approach. Complications may be divided into major and minor. Major complications include bleeding that requires transfusion, retroperitoneal hemorrhage and nonhemorrhagic complications such as pseudoaneurysm, arteriovenous fistula, arterial dissection, thrombosis and limb ischemia. Minor complications include minor bleeding, ecchymosis and hematomas. The incidence of access complications varies by the population studied. Numerous patient-related and procedure-related risk factors have been associated with vascular access-site complications. Alternate access sites, the use of fluoroscopic guidance, focus on anticoagulant and antiplatelet therapy, and arterial closure devices are all methods being investigated to prevent and reduce complications. History and physical examination are important in identifying vascular access-site complications and imag...

Role of fractional and coronary flow reserve in clinical decision making in intermediate coronary lesions

Abstract: Adequate patient selection for percutaneous coronary intervention is of the greatest importance in order to minimize early and late complications. Therefore, objective evidence for myocardial ischemia is mandatory for the management of patients with coronary artery disease, in particular in multivessel disease and those with intermediate lesions (40–70% diameter stenosis on angiography). The use of sensor-equipped guidewires for the assessment of functional coronary lesion severity has become extensive in the cardiac catheterization laboratory. The hemodynamic indices derived from intracoronary pressure or flow measurements, fractional flow reserve and coronary flow reserve, show a high agreement with noninvasive stress testing. Furthermore, deferral of percutaneous coronary intervention for hemodynamically nonsignificant lesions is associated with a low major adverse cardiac event rate. However, since these indices are based on either intracoronary pressure or flow, they do not investigate the hemodynami...

Drug-eluting stent coatings

Abstract: Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform, a drug carrier or so called ‘stent coating’ and a drug. As such, stent coating plays an important role in the performance of DES. This article will review the evolution of stent coatings and their role in the development of restenosis and thrombosis.

Potential of 3D-printed models in planning structural interventional procedures

Abstract: 3D cardiovascular models are an accurate representation of the patient's anatomy and have a huge potential in the field of intervention in structural heart disease. Its applications range from training staff to simulation of complex and challenging cases. This review article will summarize the basic principles, the techniques and the current applications.

Coronary and endovascular applications of the Absorb™ bioresorbable vascular scaffold

Abstract: Atherosclerotic cardiovascular disease is the leading cause of death and disability in the world, accounting for nearly one-third of all human mortality. In the modern era, the mainstay of therapy for established occlusive lesions in the cardiovascular tree is percutaneous balloon angioplasty and stent implantation. The procedure is widely applied, with over 2 million procedures performed annually, and the acute results are favorable in >95% of patients. Significant problems with angioplasty and stenting remain, however, including the need for early reintervention for restenosis and/or thrombosis, and the requirement for continual antiplatelet therapy as the artery heals. Furthermore, although the remarkable progress in intravascular stent development is incontrovertible, stents still generate an alarming amount of long-term complications including fracture and late thrombosis. In order to circumvent the myriad problems associated with permanent intravascular implants, stents that slowly dissolve after de...